China NMPA Drug Inspection - Bozhou Huayun Traditional Chinese Medicine Pieces Co., Ltd. - Akebia
China NMPA drug inspection for Bozhou Huayun Traditional Chinese Medicine Pieces Co., Ltd. published December 08, 2020. Drug: Akebia. On December 8, 2020, the Shanxi Provincial Drug Administration announced that seven batches of drugs failed to meet qual
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Bozhou Huayun Traditional Chinese Medicine Pieces Co., Ltd. published December 08, 2020. Drug: Akebia. On December 8, 2020, the Shanxi Provincial Drug Administration announced that seven batches of drugs failed to meet qual
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox